Capitalise on favourable exchange rates as well as receiving up to 43.5%of trial costs back through Australia’s R&D tax incentive package.

Clinical research in Australia is seeing exponential growth! Our clinical sites are vastly experienced and have access to world class key opinion leaders and scientific thought leaders across all therapeutic areas.

Five world-leading, fully equipped specialized phase 1 units able to conduct your early phase research requirements (including first in man). Each holds a robust healthy volunteer database for expedited recruitment.

Australia boasts a highly multicultural population, providing a diverse patient recruitment pool.

No US-IND or EU CTA application required to conduct research in Australia, with data collected during trials accepted for regulatory submissions globally.

Australia boasts an expedited IRB/HREC and regulatory approval process with typical full approval obtained in under a month.

Faster start up leads to faster completion, and more time on market!